Answers are grounded in this paper and cite their sources.
Overactive bladder, aging population, pharmacologic treatments, muscarinic antagonists, side effects, tolterodine, trospium, oxybutynin, solifenacin, combination antimuscarinics, urodynamic monitoring, urotoday health, urology news
No takes yet. Share an insight, caveat, or question.
Kosilov et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: